G&E Healthcare Co (XKRX:299480) COGS-to-Revenue : 0.00 (As of . 20)

View and export this data going back to 2018. Start your Free Trial

What is G&E Healthcare Co COGS-to-Revenue?

G&E Healthcare Co's Cost of Goods Sold for the six months ended in . 20 was ₩0.00 Mil. Its Revenue for the six months ended in . 20 was ₩0.00 Mil.

G&E Healthcare Co's COGS to Revenue for the six months ended in . 20 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. G&E Healthcare Co's Gross Margin % for the six months ended in . 20 was N/A%.

G&E Healthcare Co COGS-to-Revenue Historical Data

The historical data trend for G&E Healthcare Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G&E Healthcare Co COGS-to-Revenue Chart

G&E Healthcare Co Annual Data

Trend

COGS-to-Revenue

G&E Healthcare Co Semi-Annual Data

COGS-to-Revenue

G&E Healthcare Co COGS-to-Revenue Calculation

G&E Healthcare Co's COGS to Revenue for the fiscal year that ended in . 20 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=		/
	=

G&E Healthcare Co's COGS to Revenue for the quarter that ended in . 20 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=		/
	=

G&E Healthcare Co (XKRX:299480) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

G&E Healthcare Co's Gross Margin % for the six months ended in . 20 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	/
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

G&E Healthcare Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of G&E Healthcare Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

G&E Healthcare Co (XKRX:299480) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G&E Healthcare Co Ltd (XKRX:299480) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 92, Keji 5th Road, Annan District, Tainan, TWN, 70955

Website

http://www.geherbs.com.tw

G&E Healthcare Co Ltd, formerly G&E Biotech Co Ltd is a biopharmaceutical company focused on the development and commercialization of novel botanical extraction technology and products. It offers a range of products that include Hepato Protective Agent (Hepanamin) which prevent and cure for acute and chronic hepatitis, fatty liver conditions and liver toxicity infections, Botanical Healthcare product, and Botanical Anti-aging cosmetics.

G&E Healthcare Co (XKRX:299480) Headlines

No Headlines